Healthcare Sector
In Vitro & In Vivo Diagnostic Substances Industry Performance
Stock price performance - one day, 5-day, 30-day, 90-day and year-to-date - for companies within In Vitro & In Vivo Diagnostic Substances Industry.
As of: September 30, 2026
Price-Weighted
One Day
-0.41%
▲ 33%/▼ 67%
5 Days
-4.71%
▲ 33%/▼ 67%
30 Days
0.8%
▲ 33%/▼ 67%
90 Days
-8.15%
▲ 33%/▼ 67%
YTD
15.31%
▲ 67%/▼ 33%
▲ advancing / ▼ declining — share of the 3 constituents that rose vs fell over each period (equal-weight breadth).
Market-Cap Weighted
One Day
-0.2%
5 Days
-5.03%
30 Days
3.58%
90 Days
3.78%
YTD
55.94%
In Vitro & In Vivo Diagnostic Substances Industry - One Year Price Chart
Stock Performance by Company within In Vitro & In Vivo Diagnostic Substances Industry
September 30, 2026| Company | One Day | 5 Days | 30 Days | YTD | |
|---|---|---|---|---|---|
| Neogen Corporation | 0.39% | -5.82% | 10.55% | 82.57% | |
| Intellia Therapeutics Inc | -1.21% | -3.61% | -6.64% | 29.04% | |
| Volitionrx Limited | -2.77% | 1.12% | -41.21% | -95.32% | |
| In Vitro & In Vivo Diagnostic Substances Industry totals | Sign in to view the price-weighted & market-cap-weighted totals | ||||
In Vitro & In Vivo Diagnostic Substances Industry
In Vitro & In Vivo Diagnostic Substances Industry gave back ground in the latest session, off 0.41%. Pull the lens back and the move reads -4.71% over the past week and 0.8% across the month. Year to date the group sits ahead by 15.31% on a price-weighted basis — though weighted by market value, where the biggest companies carry the most sway, the year-to-date read is 55.94%.
Industry Benchmarking Dataset for Institutional Use
CommercialThe data presented above is part of our institutional-grade Industry Benchmarking Dataset, designed for integration into credit risk models, AML/KYC frameworks, portfolio analytics, and internal banking systems. The full dataset is available under a Commercial License, with delivery via API or bulk CSV datasets.
Available under institution-grade licensing frameworks with defined usage rights,
distribution scope, and integration permissions, supporting internal use,
client reporting, and enterprise-wide deployment.
Methodology
1. Data Coverage & Universe
2. Aggregation Methodology
3. Ratio Construction
4. Distribution Analytics
5. Percentile Rankings
6. Volatility & Trend Metrics
7. Composite Scores
8. Data Quality Controls
9. Update Frequency
10. Use Cases
11. Licensing & Access
Decision Framework & Data Access
Power onboarding, benchmarking, and quantitative analysis with institutional-grade datasets structured for direct integration into financial models and risk frameworks.
- Industry benchmarking datasets (valuation, growth, profitability)
- Designed for quant models, AML/KYC validation & onboarding workflows
- Consistent time-series structure (Quarterly, TTM, Annual)
- Coverage across 100+ industries and 20+ years of history
